These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34177178)

  • 1. Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.
    Arora R; Pande RK; Panwar S; Gupta V
    Indian J Crit Care Med; 2021 May; 25(5):575-579. PubMed ID: 34177178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report.
    Su CS; Kao CL
    J Med Case Rep; 2024 Jul; 18(1):344. PubMed ID: 39068499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
    Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yan Q; Liu X; Lei H; Liu R; Hu Y
    Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN/Stevens-Johnson syndrome overlap.
    Smith SD; Dodds A; Dixit S; Cooper A
    Australas J Dermatol; 2015 Nov; 56(4):298-302. PubMed ID: 25368980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
    Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
    Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of NLRP3 Inflammasome in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Shekhar M; Iqbal O; Dharan A; El-Khateeb H; Jatavallabhula K; Bu P; Bouchard C
    Med Res Arch; 2024 Jan; 12(1):. PubMed ID: 39026932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report].
    Zhang S; Liu XY; Zhang JZ; Cai L; Zhou C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):977-980. PubMed ID: 31624410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
    Al Rajaibi R; Al Rumhi T; Al Abri AM
    Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use.
    Suresh Kumar PN; Thomas B; Kumar K; Kumar S
    Indian J Psychiatry; 2005 Apr; 47(2):121-3. PubMed ID: 20711297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease severity and status in Stevens-Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs.
    Lehloenya RJ
    Front Med (Lausanne); 2022; 9():901401. PubMed ID: 36172538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Chronopoulos A; Mockenhaupt M; Pleyer U
    Ophthalmologe; 2021 May; 118(5):519-532. PubMed ID: 33725172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chantaphakul H; Sanon T; Klaewsongkram J
    Exp Ther Med; 2015 Aug; 10(2):519-524. PubMed ID: 26622347
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.